Scientific Sessions 2024  /  Gene Therapy in the Cardiology Clinic: Ready for Prime Time?  /  Gene Therapy in 2024: What Are the Options?
Logo

American Heart Association

  132
  0

Final ID:

Gene Therapy in 2024: What Are the Options?

  • Helms, Adam  ( UNIVERSITY OF MICHIGAN , Ann Arbor , Michigan , United States )
  • Rosanno, Joseph  ( Children's Hospital of Philadelphia , Philadelphia , Pennsylvania , United States )
  • Giacca, Mauro  ( King's College London , London , United Kingdom )
    • Author Disclosures:
    Adam Helms: DO have relevant financial relationships ; Consultant:Tenaya Therapeutics:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Lexeo Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Tenaya Therapeutics:Active (exists now) | Joseph Rosanno: No Answer | Mauro Giacca: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Gene Therapy in the Cardiology Clinic: Ready for Prime Time?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
So How Do We Determine the Right Strategy for the Right Patient?

Watkins Hugh, Seidman Christine

Gene Therapy for Lysosomal Storage Disorders: From the Bench to the Bedside

Adler Eric, Greenberg Barry

More abstracts from these authors:
Gene Therapy Strategies, Advantages, and Pitfalls

Helms Adam, Elliott Perry, Giacca Mauro

Programming the Heart to a Regenerative State

Giacca Mauro

You have to be authorized to contact abstract author. Please, Login
Not Available